Boehringer Ingelheim launches quarterable Previcox tablets after FDA approval

Boehringer Ingelstadt launched a quarterable format for Previcox (firocoxib) Chewable Tablets following FDA approval, according to Today's Veterinary Business. The company said "the double-scored 57-milligram and 227-milligram tablets can be divided into quarters, allowing" dosing "for dogs weighing as little as 7 pounds," and "quartered tablets can be stored in their original packaging for up to one month."

What the new design changes

According to Today's Veterinary Business, the COX-2 selective NSAID "is approved for the control of pain and inflammation associated with osteoarthritis in dogs and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs." Boehringer said "the core formulation and dose strengths remain the same."

The company said "the updated packaging includes an industry-standard round bottle" and eliminates internal cotton to reduce material use. According to Today's Veterinary Business, "the tablets will roll out progressively throughout 2026 and 2027, beginning with the 60-count bottles."

The inventory decision this frames

For practices stocking multiple Previcox strengths, the quarterable format may consolidate SKUs. A practice that previously carried 57-mg, 227-mg, and potentially off-label split tablets for borderline-weight cases can now cover a wider dosing range with two quarterable strengths. That reduces shelf space, simplifies reorder decisions, and may lower carrying costs if slower-moving strengths get replaced by a single quarterable option.

The one-month storage window for quartered tablets matters for practices with lower osteoarthritis caseloads or those dispensing smaller quantities. Previously, splitting a tablet meant immediate use or waste, and the extended shelf life changes the reorder calculation for clinics that move NSAIDs slowly.

More reads like this, free, weekly. subscribe to VeterinaryPracticeNow.

Where this lands for the clinician

For associate DVMs, the quarterable format addresses the borderline-weight dosing problem without off-label splitting. A 7-pound dog that previously required rounding up to the next tablet size or splitting a tablet outside labeled use now fits within the approved dosing range. That reduces liability and may improve compliance in cases where owners balked at giving a larger dose than the dog's weight suggested.

For owner-DVMs running inventory, the SKU consolidation is the operational win. Fewer strengths to stock means simpler ordering, less shelf clutter, and potentially lower waste writeoffs if you have been carrying multiple sizes that move at different rates. The quarterable design does not eliminate the need to stock both the 57-mg and 227-mg strengths, but it may eliminate the need for intermediate sizes or off-label splitting protocols.

Our read

This is a straightforward operational improvement for a high-volume therapeutic class. The quarterable format does not change the drug's efficacy or safety profile, but it simplifies dosing decisions and inventory management in a category where most practices already stock Previcox. The one-month storage window for quartered tablets is the detail that makes the format practical rather than theoretical, because without it, the quarterable design would still force immediate use or waste.

The progressive rollout through 2027 means practices will not see the full SKU consolidation benefit immediately, and the 60-count bottles rolling out first may not be the size every practice orders. Watch for pricing on the quarterable format versus the current design. If Boehringer holds pricing flat, the operational benefit is pure upside. If the quarterable format carries a premium, the SKU consolidation has to justify the added cost per dose.

For practices already splitting tablets off-label or stocking multiple strengths to cover borderline cases, the quarterable format is worth ordering as soon as it is available in your preferred bottle size. For practices that have been rounding up to the next tablet size without issue, the quarterable format is a convenience rather than a necessity, and the decision comes down to whether the SKU consolidation simplifies your inventory enough to justify switching.

← Back to the Newsdesk